Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402389 · ClinicalTrials.gov registry record · Phase 2
Use of Omega-3 Fatty Acids for Perinatal Depression
A Phase 2 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00402389: Completed Phase 2 study, sponsored by University of Arizona.
NCT00402389 is a Phase 2 study that has completed, run by University of Arizona. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00402389, a Phase 2 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of using omega-3 fatty acids to treat women with perinatal depression.
Interventions
- DRUG Placebo
- DRUG Omega-3 Fatty Acids (EPA plus DHA)
- BEHAVIORAL Supportive psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-06 |
| Est. Completion | 2006-01 |
| Phase | Phase 2 |
What the finished NCT00402389 record still lists
NCT00402389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00402389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00402389 about?
NCT00402389 is a clinical study titled "Use of Omega-3 Fatty Acids for Perinatal Depression". This study will evaluate the effectiveness of using omega-3 fatty acids to treat women with perinatal depression.
What is the current status of trial NCT00402389?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2004-06. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00402389?
The interventions under investigation include: Placebo (DRUG), Omega-3 Fatty Acids (EPA plus DHA) (DRUG), Supportive psychotherapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00402389?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00402389's enrollment target sits among peer trials
50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia